The Latest News
Find Articles about the things you need to know about the industry.
Why Dermatologists and Plastic Surgeons Are Getting Ready to Join Other Health Care Workers Fighting COVID-19
by Leah Prinzivalli General care doctors and nurses staffing hospitals are among those on the front-lines in the fight against the coronavirus. But with a medical crisis that has so far exceeded 59,000 positive cases of COVID-19 nationwide, specialized physicians like dermatologists and plastic surgeons may also be called...
Coronavirus and Plastic Surgery
from the American Academy of Plastic Surgeons In accordance with the new CMS recommendation that all elective surgeries, non-essential medical, surgical and dental procedures be delayed during the COVID-19 outbreak, the American Society of Plastic Surgeons recommends that all plastic surgeons cease providing any elective...
Virtual Consultations Are The Next Big Thing In Plastic Surgery
by Zoe Weiner Plastic surgery is no joke, and finding the most qualified doctor to fit your needs is one of the most important parts of the process. Not only will he or she be the one performing the surgery, but they can help manage your expectations...
American College of Surgeons Recommendations for Elective Surgery During the Pandemic
The American College of Surgeons released recommendations for management of elective surgical procedures and essential resources following a careful review of the current situation surrounding COVID-19. Until the predicted inflection point in the exposure graph has been passed and a potentially rapid and overwhelming uptick...
Botox: The Drug That’s Treating Everything
Source: Time Magazine During a recent therapy session, one of Dr. Norman Rosenthal’s regulars said he was considering suicide. It wasn’t the first time the patient had entertained the thought, and even though he was on antidepressants and always kept up with his appointments, Rosenthal, a...
The FDA Accepted Revance Therapeutics’ Application for Approval Of Its Botox Competitor
Source: The Motley Fool A new alternative to Allergan's (NYSE: AGN) blockbuster aesthetics treatment Botox may be available by the end of 2020. On Thursday, Revance Therapeutics (NASDAQ: RVNC) announced the Food and Drug Administration (FDA) accepted its application for approval of DAXI (daxibotulinumtoxinA for injection), a long-lasting neurotoxin for use in treating...